Kedalion Therapeutics Revenue and Competitors

Location

$5M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Kedalion Therapeutics's estimated annual revenue is currently $930k per year.(i)
  • Kedalion Therapeutics's estimated revenue per employee is $77,500
  • Kedalion Therapeutics's total funding is $5M.

Employee Data

  • Kedalion Therapeutics has 12 Employees.(i)
  • Kedalion Therapeutics grew their employee count by -20% last year.

Kedalion Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Kedalion Therapeutics?

Kedalion Therapeutics is a clinical-stage, venture-funded ophthalmic drug company based in Menlo Park, CA. Kedalion's AcuStream technology delivers topical drugs to the eye in a precise and accurate manner that enables comparable efficacy with an 80% reduction in dose compared to standard drops, and a significantly improved side effect profile along with patient comfort and convenience following self-administration.

keywords:N/A

$5M

Total Funding

12

Number of Employees

$930k

Revenue (est)

-20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3M12-20%N/A
#2
$1M120%N/A
#3
$0.6M12-68%$4M
#4
$1M120%N/A
#5
$1.7M120%N/A